ISRCTN81965907
Completed
未知
The value of faecal calprotectin (CPT) in monitoring the response to treatment of patients with inflammatory bowel disease
Department of Health (UK)0 sites80 target enrollmentSeptember 12, 2003
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Inflammatory bowel disease
- Sponsor
- Department of Health (UK)
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •80 patients
Exclusion Criteria
- •Not provided at time of registration
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Relevance of fecal calprotectin as a biomarker to predict the outcome of Adalimumab therapy in Ulcerative Colitis patients.lcerative ColitisJPRN-UMIN000022104Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Division of Internal Medicine54
Recruiting
Not Applicable
Study on the usefulness of fecal calprotectin in ulcerative colitis and the relevance of other biomarkerslcerative colitisJPRN-UMIN000052832Ehime University150
Active, not recruiting
Not Applicable
Does measurement of fecal calprotectin levels help distinguish various colitis?Diseases of the digestive systemKCT0003598Eulji University Hospital30
Completed
Not Applicable
Can fecal calprotectin be a predictive marker for refractoriness in patients with ulcerative colitis ?lcerative colitisJPRN-UMIN000024146Showa University, School of Medicine100
Recruiting
Not Applicable
The use of fecal calprotectin in detecting immunotherapy induced colitis and feasibility for the use of immunohistochemical markers in patients receiving checkpoint inhibitors’- a pilot studycolitisNL-OMON25248KI-AV50